IP Library Granted Patent US 12,702,807
Granted Patent B2
US 12,702,807 · App. 17/770,956 · Granted Aug 11, 2026

Methods for making microneedles using adjustment of component solubility in casting formulations

Inventors: Richard N. Terry (Atlanta, GA); Mark R. Prausnitz (Atlanta, GA)
Assignee: Georgia Tech Research Corporation
A61M37/0015A61M2037/0023A61M2037/0046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,702,807
App. No.
17/770,956
Filed
Apr 21, 2022
Granted
Aug 11, 2026
Kind
B2
Art Unit
1742
USPC
264/299
Abstract

Methods are provided that involve the intentional and controlled precipitation of a drug or active agent, or a reduction of solubility of a polymer or other film-forming component of a formulation, or a combination of both methods, to improve the processes for making microneedles or other objects by casting into molds and the resulting parts produced by casting. The selective reduction in solubility of formulation components solves many problems associated with the casting of polymer formulations into molds. The methods are preferably adapted for making microneedles of biodegradable polymer and drug composites, and may also be used to produce other solid objects formed by casting into molds of compositions containing polymers and active agents.

Claims (45)

1 . A method for making a microneedle, the method comprising:

preparing a casting solution which comprises at least one organic solvent and a polymer and, optionally, a substance of interest, wherein the polymer and the substance of interest, if present, are fully dissolved in the casting solution;

(i) adding a non-solvent for the polymer to the casting solution, and/or (ii) evaporating at least a portion of the at least one organic solvent, wherein the adding and/or evaporating are effective to reduce the effective molecular volume of the polymer in the casting solution; and then

casting the casting solution in a mold for the microneedle,

wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of (i) adding the nonsolvent for the polymer to the casting solution, and/or (ii) evaporating the at least a portion of the at least one organic solvent, wherein the polymer in the casting solution that is cast has a concentration that is within 5% of the solubility limit of the polymer in a solvent system of the casting solution comprising the at least one organic solvent.

2 . The method of claim 1 , wherein the casting solution comprises a substance of interest, and wherein the adding a non-solvent to the casting solution and/or the evaporating at least a portion of the at least one organic solvent is/are effective to precipitate the substance of interest as a colloid or suspension in the casting solution.

3 . The method of claim 1 , wherein the casting comprises drying, centrifugation, and/or application of a vacuum to the casting solution in the mold.

4 . The method of claim 1 , wherein the at least one organic solvent comprises two different organic solvents.

5 . The method of claim 1 , wherein the mold is formed of silicone or another elastomer.

6 . The method of claim 5 , wherein the mold comprises a cavity having a microneedle tip portion and a funnel portion.

7 . The method of claim 6 , wherein the casting solution forms the microneedle tip portion, and the reduction of the effective molecular volume of the polymer is effective to avoid formation of a polymeric film on the funnel portion.

8 . The method of claim 1 , wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of (i) adding a non-solvent for the polymer to the casting solution to precipitate the substance of interest as a colloid or suspension in the casting solution.

9 . The method of claim 1 , wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of (ii) evaporating at least a portion of the at least one organic solvent to precipitate the substance of interest as a colloid or suspension in the casting solution.

10 . The method of claim 1 , wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of (i) adding a non-solvent for the polymer to the casting solution, and (ii) evaporating at least a portion of the at least one organic solvent, to precipitate the substance of interest as a colloid or suspension in the casting solution.

11 . The method of claim 1 , wherein the polymer in the casting solution that is cast has a concentration that is within 1% to 2% of the solubility limit of the polymer in the solvent system of the casting solution comprising the at least one organic solvent.

12 . The method of claim 1 , wherein the microneedle is part of a microneedle array.

13 . The method of claim 1 , wherein the substance of interest is present in the casting solution and comprises a prophylactic or therapeutic agent.

14 . The method of claim 13 , wherein the polymer is a biodegradable polymer.

15 . The method of claim 14 , wherein the substance of interest comprises a contraceptive hormone.

16 . A method for making a microneedle, the method comprising the following ordered steps:

(i) preparing a casting solution which comprises at least one organic solvent and a polymer and a substance of interest, wherein the polymer is fully dissolved in the at least one organic solvent of the casting solution;

(ii) adding a non-solvent for the polymer to the casting solution in an amount effective to reduce the effective molecular volume of the polymer in the casting solution; and then

(iii) casting the casting solution in a mold for the microneedle, wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of adding the non-solvent for the polymer to the casting solution.

17 . The method of claim 16 , wherein the mold comprises a cavity having a microneedle tip portion and a funnel portion, and wherein the casting solution forms the microneedle tip portion, and the reduction of the effective molecular volume of the polymer is effective to avoid formation of a polymeric film on the funnel portion.

18 . The method of claim 16 , wherein the adding the non-solvent for the polymer to the casting solution causes the substance of interest to precipitate as a colloid or suspension in the casting solution.

19 . The method of claim 16 , wherein the polymer in the casting solution that is cast has a concentration that is within 5% of the solubility limit of the polymer in the solvent system of the casting solution comprising the at least one organic solvent.

20 . The method of claim 16 , wherein the microneedle is part of a microneedle array.

21 . The method of claim 16 , wherein the substance of interest comprises a prophylactic or therapeutic agent.

22 . The method of claim 21 , wherein the polymer is a biodegradable polymer.

23 . The method of claim 22 , wherein the substance of interest comprises a contraceptive hormone.

24 . A method for making a microneedle, the method comprising the following ordered steps:

(i) preparing a casting solution which comprises at least one organic solvent and a polymer and a substance of interest, wherein the polymer is fully dissolved in the at least one organic solvent of the casting solution;

(ii) evaporating at least a portion of the at least one organic solvent in an amount effective to reduce the effective molecular volume of the polymer in the casting solution; and then

(iii) casting the casting solution in a mold for the microneedle, wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of evaporating the at least a portion of the at least one organic solvent,

wherein the polymer in the casting solution that is cast has a concentration that is within 5% of the solubility limit of the polymer in the solvent system of the casting solution comprising the at least one organic solvent.

25 . A method for making a microneedle, the method comprising the following ordered steps:

(i) preparing a casting solution which comprises at least one organic solvent and a polymer and a substance of interest, wherein the polymer is fully dissolved in the at least one organic solvent of the casting solution;

(ii) evaporating at least a portion of the at least one organic solvent in an amount effective to reduce the effective molecular volume of the polymer in the casting solution; and then

(iii) casting the casting solution in a mold for the microneedle, wherein the casting solution that is cast in the mold for the microneedle is the casting solution produced by the step of evaporating the at least a portion of the at least one organic solvent,

wherein the evaporating at least a portion of the at least one organic solvent causes the substance of interest to precipitate as a colloid or suspension in the casting solution.

26 . The method of claim 25 , wherein the mold comprises a cavity having a microneedle tip portion and a funnel portion, and wherein the casting solution forms the microneedle tip portion, and the reduction of the effective molecular volume of the polymer is effective to avoid formation of a polymeric film on the funnel portion.

27 . The method of claim 25 , wherein the microneedle is part of a microneedle array.

28 . The method of claim 25 , wherein the substance of interest comprises a prophylactic or therapeutic agent.

29 . The method of claim 28 , wherein the polymer is a biodegradable polymer.

30 . The method of claim 29 , wherein the substance of interest comprises a contraceptive hormone.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: TERRY, RICHARD N.; PRAUSNITZ, MARK R.
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 062187/0986 →
Continuity (3)
Provisional Application 62933739 · Nov 11, 2019
Provisional Application 62924580 · Oct 22, 2019
Related Publication 20220401715A1 · Dec 22, 2022
References Cited (70)
US 4097943A · O'Connell · 1978 [cited by applicant]
US 6007836A · Denzer · 1999 [cited by applicant]
US 6334856B1 · Allen et al. · 2002 [cited by applicant]
US 6503231B1 · Prausnitz et al. · 2003 [cited by applicant]
US 6611707B1 · Prausnitz et al. · 2003 [cited by applicant]
US 6611717B1 · Clark et al. · 2003 [cited by applicant]
US 6656147B1 · Gertsek et al. · 2003 [cited by applicant]
US 6743211B1 · Prausnitz et al. · 2004 [cited by applicant]
US 6945952B2 · Kwon · 2005 [cited by applicant]
US 7182747B2 · Kwon · 2007 [cited by applicant]
US 7211062B2 · Kwon · 2007 [cited by applicant]
US 7226439B2 · Prausnitz et al. · 2007 [cited by applicant]
US 7516845B2 · Lang et al. · 2009 [cited by applicant]
US 7918814B2 · Prausnitz et al. · 2011 [cited by applicant]
US 8062573B2 · Kwon · 2011 [cited by applicant]
US 8101114B2 · Park et al. · 2012 [cited by applicant]
US 8257324B2 · Prausnitz et al. · 2012 [cited by applicant]
US 8419708B2 · Tokumoto et al. · 2013 [cited by applicant]
US 8808225B2 · Prausnitz et al. · 2014 [cited by applicant]
US 9302903B2 · Park et al. · 2016 [cited by applicant]
US 9364426B2 · Gill et al. · 2016 [cited by applicant]
US 10265511B2 · McAllister et al. · 2019 [cited by applicant]
US 10828478B2 · McAllister et al. · 2020 [cited by applicant]
US 10940301B2 · McAllister et al. · 2021 [cited by applicant]
US 20020192273A1 · Buseman et al. · 2002 [cited by applicant]
US 20030187394A1 · Wilkinson et al. · 2003 [cited by applicant]
US 20050228340A1 · Cleary et al. · 2005 [cited by applicant]
US 20060084942A1 · Kim et al. · 2006 [cited by applicant]
US 20070088248A1 · Glenn et al. · 2007 [cited by applicant]
US 20080114298A1 · Cantor et al. · 2008 [cited by applicant]
US 20080183144A1 · Trautman et al. · 2008 [cited by applicant]
US 20080245764A1 · Pirk · 2008 [cited by examiner]
US 20090118662A1 · Schnall · 2009 [cited by applicant]
US 20090182306A1 · Lee · 2009 [cited by examiner]
US 20100069726A1 · Levinson · 2010 [cited by applicant]
US 20100256568A1 · Frederickson et al. · 2010 [cited by applicant]
US 20100262081A1 · Lee et al. · 2010 [cited by applicant]
US 20110152792A1 · Takada · 2011 [cited by applicant]
US 20110245728A1 · Eppstein et al. · 2011 [cited by applicant]
US 20120027810A1 · Chen et al. · 2012 [cited by applicant]
US 20120041337A1 · Ferguson et al. · 2012 [cited by applicant]
US 20120078189A1 · Ogawa et al. · 2012 [cited by applicant]
US 20120109065A1 · Backes · 2012 [cited by applicant]
US 20130006187A1 · Kobayashi et al. · 2013 [cited by applicant]
US 20130023749A1 · Afanaswelcz et al. · 2013 [cited by applicant]
US 20130158482A1 · Davis et al. · 2013 [cited by applicant]
US 20140188041A1 · Moore et al. · 2014 [cited by applicant]
US 20140276589A1 · Bayramov et al. · 2014 [cited by applicant]
US 20160213908A1 · McAllister et al. · 2016 [cited by applicant]
US 20170057124A1 · Wakamatsu · 2017 [cited by examiner]
US 20180078498A1 · Petersson · 2018 [cited by examiner]
US 20180193256A1 · Kabata et al. · 2018 [cited by applicant]
US 20180333898A1 · Francis et al. · 2018 [cited by applicant]
US 20190015651A1 · Tadros et al. · 2019 [cited by applicant]
US 20200238065A1 · Prausnitz et al. · 2020 [cited by applicant]
CN 103203072A · 2013 [cited by applicant]
JP 2007089792A · 2007 [cited by applicant]
JP 2009039171A · 2009 [cited by applicant]
JP 2011224332A · 2011 [cited by applicant]
JP 2012196426A · 2012 [cited by applicant]
JP 2012200572A · 2012 [cited by applicant]
JP 2016074924A · 2013 [cited by applicant]
KR 100682534B1 · 2007 [cited by applicant]
WO 2010140760A2 · 2010 [cited by applicant]
WO 2013096026A1 · 2013 [cited by applicant]
WO WO2014077242A1 · 2014 [cited by examiner]
WO 2017043627A1 · 2017 [cited by applicant]
Vora, L.K., et al., Novel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug, Journal of Interdisciplinary Nanomedicine, vol. 3, No. 2 (2018), pp. 89-101. (Year: 2018). [cited by examiner]
Li, W., et al., Rapidly separable microneedle patch for the sustained release of a contraceptive, Nature Biomedical Engineering, vol. 2 (Mar. 2019), pp. 220-229. (Year: 2019). [cited by examiner]
PCT International Search Report and Written Opinion for PCT Application No. PCT/US2020/056939 mailed Oct. 22, 2020 (16 pages). [cited by applicant]